Increased teicoplanin doses are associated with improved serum levels but not drug toxicity.
about
Safety profiles of old and new antimicrobials for the treatment of MRSA infections.Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.Effects of teicoplanin on cell number of cultured cell linesTools for the Individualized Therapy of Teicoplanin for Neonates and Children.Enhanced loading regimen of teicoplanin is necessary to achieve therapeutic pharmacokinetics levels for the improvement of clinical outcomes in patients with renal dysfunction.Impact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant bacteremia
P2860
Increased teicoplanin doses are associated with improved serum levels but not drug toxicity.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Increased teicoplanin doses ar ...... levels but not drug toxicity.
@ast
Increased teicoplanin doses ar ...... levels but not drug toxicity.
@en
type
label
Increased teicoplanin doses ar ...... levels but not drug toxicity.
@ast
Increased teicoplanin doses ar ...... levels but not drug toxicity.
@en
prefLabel
Increased teicoplanin doses ar ...... levels but not drug toxicity.
@ast
Increased teicoplanin doses ar ...... levels but not drug toxicity.
@en
P2093
P1433
P1476
Increased teicoplanin doses ar ...... levels but not drug toxicity.
@en
P2093
Adam Barnett
Amy L Chue
Andrew Lovering
David Wyllie
Lorrayne Jefferies
Tomide Isinkaye
P356
10.1016/J.JINF.2013.08.018
P577
2013-09-03T00:00:00Z